These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 32923130)

  • 1. Regulatory T cells do not suppress rather activate human basophils by IL-3 and STAT5-dependent mechanisms.
    Das M; Stephen-Victor E; Bayry J
    Oncoimmunology; 2020 Jun; 9(1):1773193. PubMed ID: 32923130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory T cells induce activation rather than suppression of human basophils.
    Sharma M; Das M; Stephen-Victor E; Galeotti C; Karnam A; Maddur MS; Bruneval P; Kaveri SV; Bayry J
    Sci Immunol; 2018 May; 3(23):. PubMed ID: 29802207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
    Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y
    Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCL4 promoted the production of CD4
    Xu T; Zhao J; Wang X; Meng Y; Zhao Z; Bao R; Deng X; Bian J; Yang T
    Autoimmunity; 2020 Aug; 53(5):289-296. PubMed ID: 32538218
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative dose-responses of recombinant human IL-2 and IL-7 on STAT5 phosphorylation in CD4+FOXP3- cells versus regulatory T cells: a whole blood perspective.
    Dupont G; Demaret J; Venet F; Malergue F; Malcus C; Poitevin-Later F; Morel J; Monneret G
    Cytokine; 2014 Sep; 69(1):146-9. PubMed ID: 24947990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anti-CXCL4 antibody depletes CD4(+)CD25(+)FOXP3(+) regulatory T cells in CD4+ T cells from chronic osteomyelitis patients by the STAT5 pathway.
    Huang K; Ge S
    Ann Palliat Med; 2020 Sep; 9(5):2723-2730. PubMed ID: 32954739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose IL-2 expands CD4
    Li Y; Liu X; Wang W; Wang S; Zhang J; Jiang S; Wang Y; Li L; Li J; Zhang Y; Huang H
    Ren Fail; 2018 Nov; 40(1):280-288. PubMed ID: 29619880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrogen-Rich Saline Ameliorates Allergic Rhinitis by Reversing the Imbalance of Th1/Th2 and Up-Regulation of CD4+CD25+Foxp3+Regulatory T Cells, Interleukin-10, and Membrane-Bound Transforming Growth Factor-β in Guinea Pigs.
    Xu F; Yu S; Qin M; Mao Y; Jin L; Che N; Liu S; Ge R
    Inflammation; 2018 Feb; 41(1):81-92. PubMed ID: 28894978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of Foxp3 expression in mouse and human Treg is IL-2/STAT5 dependent: implications for the NOD STAT5B mutation in diabetes pathogenesis.
    Murawski MR; Litherland SA; Clare-Salzler MJ; Davoodi-Semiromi A
    Ann N Y Acad Sci; 2006 Oct; 1079():198-204. PubMed ID: 17130555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells.
    Burchill MA; Yang J; Vogtenhuber C; Blazar BR; Farrar MA
    J Immunol; 2007 Jan; 178(1):280-90. PubMed ID: 17182565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-10 derived from Hepatocarcinoma cells improves human induced regulatory T cells function via JAK1/STAT5 pathway in tumor microenvironment.
    Zhang S; Gan X; Qiu J; Ju Z; Gao J; Zhou J; Shi C; Zhu Y; Li Z
    Mol Immunol; 2021 May; 133():163-172. PubMed ID: 33667986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased frequencies and impaired functions of the CD31
    Huang L; Zheng Y; Yuan X; Ma Y; Xie G; Wang W; Chen H; Shen L
    Clin Exp Immunol; 2017 Mar; 187(3):441-454. PubMed ID: 27997991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoembryonic antigen-related cell adhesion molecule 1 controls IL-2-dependent regulatory T-cell induction in immune-mediated hepatitis in mice.
    Horst AK; Wegscheid C; Schaefers C; Schiller B; Neumann K; Lunemann S; Langeneckert AE; Oldhafer KJ; Weiler-Normann C; Lang KS; Singer BB; Altfeld M; Diehl L; Tiegs G
    Hepatology; 2018 Jul; 68(1):200-214. PubMed ID: 29377208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of antigen specific CD4(+)CD25(+)Foxp3(+)T regulatory cells from naïve natural thymic derived T regulatory cells.
    Hall BM; Tran GT; Robinson CM; Hodgkinson SJ
    Int Immunopharmacol; 2015 Oct; 28(2):875-86. PubMed ID: 25882104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
    Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
    Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT5 in human basophils: IL-3 is required for its FcεRI-mediated phosphorylation.
    Verweij MM; Sabato V; Nullens S; Bridts CH; De Clerck LS; Stevens WJ; Ebo DG
    Cytometry B Clin Cytom; 2012 Mar; 82(2):101-6. PubMed ID: 22102340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-33 Effect on Quantitative Changes of CD4
    Ryba-Stanisławowska M; Werner P; Skrzypkowska M; Brandt A; Myśliwska J
    Mediators Inflamm; 2016; 2016():9429760. PubMed ID: 27761063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of high-dose IFNalpha2b on regional lymph node metastases of human melanoma: modulation of STAT5, FOXP3, and IL-17.
    Wang W; Edington HD; Rao UN; Jukic DM; Radfar A; Wang H; Kirkwood JM
    Clin Cancer Res; 2008 Dec; 14(24):8314-20. PubMed ID: 19088050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin I2-IP signalling regulates human Th17 and Treg cell differentiation.
    Liu W; Li H; Zhang X; Wen D; Yu F; Yang S; Jia X; Cong B; Ma C
    Prostaglandins Leukot Essent Fatty Acids; 2013 Oct; 89(5):335-44. PubMed ID: 24035274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo maintenance of human regulatory T cells during CD25 blockade.
    Huss DJ; Mehta DS; Sharma A; You X; Riester KA; Sheridan JP; Amaravadi LS; Elkins JS; Fontenot JD
    J Immunol; 2015 Jan; 194(1):84-92. PubMed ID: 25416807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.